
Adrenomed bags €24m in growth financing
The company said it will use the proceeds to advance clinical testing of adrecizumab, the companies first-in-class antibody targeting endothelial...

Epigenetic drugs can increase tumour malignancy
In Nature Cell Biology the team headed by Salvador Aznar Benitah and Fran Supek reported that genetic inactivation of histone H3...

AMR: Novo Holdings funds companies with €18m
"Three additional investments into companies developing innovative novel anti-infective therapies were made in late 2018", Novo Holdings...

Investors pool €27m for new Proteomics tech
Developed at the University of Cambridge, Fluidic Analytics’ platform is designed to give insights into the way that proteins fold, aggregate and...

Breakthrough in restless legs syndrome
According to Dirk Czesni, "the mechanisms for Restless Legs Syndrome are still not completely understood. "We have shown that the...

EMA greenlights two orphan drugs and two biosimilars
Two of six new meds to be approved in Europe are biosimilar medicines and have been backed by the European Medicines Agency (EMA) this...

Microbiome defines gut conditions
Studying over 1,700 individuals delivered differences in gut microbiome composition and function among patients with the inflammatory...